相关实验视频

Updated: Jun 17, 2025

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Published on: June 9, 2016

针对中枢神经系统原发性瘤患者的综合基因分析和分子导向治疗

Julia C Kuehn^1,2, Patrick Metzger^3,4, Nicolas Neidert^2,5,6

¹Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

NPJ precision oncology

|August 14, 2024

概括

个体分子分析可以指导脑癌治疗. 生物标志物指导疗法显示出有希望的疗效,在现实环境中,总体响应率为30%,疾病控制率为50%.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
神经瘤学神经瘤学

背景情况:

针对原发性脑瘤的个性化治疗是有限的,尽管分子分析的进步.
需要对成人大脑癌症的生物标志物指导治疗疗效的现实数据.

研究的目的:

评估成年脑癌患者个体分子分析的可行性.
在现实环境中评估生物标志物指导治疗的疗效.
为了确定经常改变的路径,指导治疗建议.

主要方法:

对102名患有21种脑瘤类型的成年患者的遗传特征,治疗建议和临床结果的分析.
对来自弗赖堡分子瘤委员会数据的回顾性审查.
分子变化的相关性与治疗反应和存活率.

主要成果:

个性化治疗建议是由细胞周期,BRAF和mTOR途径的改变驱动的.
在71%的患者中推了分子信息化疗法,在32%的患者中实施了分子信息化疗法.
针对性治疗实现了50%的疾病控制率和30%的整体应答率,其中31%的患者实现了至少1.3的无进展生存率.

结论:

在现实世界中,分子导向治疗对脑癌是有效的.
生物标志物分层临床试验对于推进脑癌治疗至关重要.
个体分子分析可以为脑瘤患者提供个性化治疗策略.

更多相关视频

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...